secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0001193125-25-137089
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics gets Nasdaq delisting notice for negative stockholders' equity
--------------------------------------------------------------------------------

- Company reported stockholders' equity deficit of $23.6M as of March 31, 2025, failing Nasdaq's $2.5M minimum.
- Nasdaq staff determined to delist securities; company must request a hearing by June 10, 2025.
- Common stock (PSTV) continues trading on Nasdaq Capital Market pending hearing decision.
- Company plans to appeal; hearing typically scheduled 30-45 days after request.
- Previously regained compliance on equity requirement on March 7, 2025, but fell back into non-compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525137089/0001193125-25-137089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525137089/d39292d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-137089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer